- Home
- RNAC vs ABSI Comparison
RNAC vs ABSI Comparison
Compare RNAC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- ABSI
- Stock Information
- Founded
- RNAC 2007
- ABSI 2011
- Country
- RNAC United States
- ABSI United States
- Employees
- RNAC N/A
- ABSI N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- RNAC Health Care
- ABSI Health Care
- Exchange
- RNAC Nasdaq
- ABSI Nasdaq
- Market Cap
- RNAC 291.7M
- ABSI 353.8M
- IPO Year
- RNAC 2016
- ABSI 2021
- Fundamental
- Price
- RNAC $10.42
- ABSI $2.80
- Analyst Decision
- RNAC Strong Buy
- ABSI Strong Buy
- Analyst Count
- RNAC 7
- ABSI 5
- Target Price
- RNAC $41.00
- ABSI $8.40
- AVG Volume (30 Days)
- RNAC 86.8K
- ABSI 2.5M
- Earning Date
- RNAC 05-08-2025
- ABSI 05-13-2025
- Dividend Yield
- RNAC N/A
- ABSI N/A
- EPS Growth
- RNAC N/A
- ABSI N/A
- EPS
- RNAC N/A
- ABSI N/A
- Revenue
- RNAC $34,173,000.00
- ABSI $4,534,000.00
- Revenue This Year
- RNAC N/A
- ABSI $158.58
- Revenue Next Year
- RNAC N/A
- ABSI $93.12
- P/E Ratio
- RNAC N/A
- ABSI N/A
- Revenue Growth
- RNAC 31.91
- ABSI N/A
- 52 Week Low
- RNAC $8.85
- ABSI $2.01
- 52 Week High
- RNAC $41.87
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- RNAC 39.42
- ABSI 44.49
- Support Level
- RNAC $11.18
- ABSI $2.85
- Resistance Level
- RNAC $13.10
- ABSI $3.16
- Average True Range (ATR)
- RNAC 0.90
- ABSI 0.20
- MACD
- RNAC 0.04
- ABSI -0.03
- Stochastic Oscillator
- RNAC 24.61
- ABSI 19.57
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.